Internal Medicine, Hematology & Oncology · Victorville, CA
NPI
1043316656
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
12677 Hesperia Rd, Suite 170
Victorville, CA, 92395
Phone (760) 952-0040
Medicare paid, 2024
$407K
19,803 services
Medicare patients, 2024
483
Average age 73
Drug cost, 2024
$5.8M
7,375 prescriptions
Company payments, 2025
$4,696
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nanda Biswas was code J1642 (injection, heparin sodium, (heparin lock flush), per 10 units), 2,430 times for 11 patients. In total Nanda Biswas billed 19,803 services in 71 codes, and Medicare paid $407K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 2,430 | 11 | $0.01 | $30.01 |
| 99232 Hospital E&M - Subsequent | Facility | 1,383 | 241 | $62.74 | $87K |
| 99214 Office E&M - Established | Office | 409 | 206 | $88.42 | $36K |
| 99222 Hospital E&M - Initial | Facility | 287 | 243 | $103.91 | $30K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 206 | 21 | $0.46 | $94.8 |
| 99213 Office E&M - Established | Office | 181 | 108 | $55.52 | $10K |
| 96365 Intravenous Infusion, Hydration | Office | 67 | 13 | $51.33 | $3,439 |
| 99204 Office E&M - New | Office | 54 | 54 | $122.68 | $6,625 |
By year: 2022 $398K for 33,634 services; 2023 $530K for 42,776 services; 2024 $407K for 19,803 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nanda Biswas prescribed most often to Medicare patients was Atorvastatin Calcium, with 402 prescriptions and refills. In total Nanda Biswas wrote 7,375 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 402 | 1,009 | 121 | $3,675 |
| Amlodipine Besylate Generic | 313 | 718 | 78 | $1,430 |
| Omeprazole Generic | 264 | 489 | 54 | $2,835 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 222 | 274 | 50 | $8,160 |
| Levothyroxine Sodium Generic | 221 | 597 | 59 | $2,148 |
| Metformin Hcl Generic | 217 | 470 | 56 | $1,435 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 208 | 208 | 37 | $5,951 |
| Lisinopril Generic | 208 | 457 | 53 | $1,236 |
| Losartan Potassium Generic | 180 | 453 | 48 | $1,547 |
| Gabapentin Generic | 149 | 227 | 39 | $2,431 |
| Eliquis Apixaban | 138 | 190 | 32 | $108K |
| Hydrochlorothiazide Generic | 126 | 274 | 31 | $426 |
| Pantoprazole Sodium Generic | 114 | 267 | 33 | $1,530 |
| Furosemide Generic | 105 | 228 | 30 | $504 |
| Simvastatin Generic | 96 | 261 | 24 | $726 |
Brand drugs: 1,308 claims; generic drugs: 6,005 claims; opioid claims: 343.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nanda Biswas $4,696 ($4,696 in general payments such as food, travel and fees) from 38 companies. The largest payer was Novartis Pharmaceuticals Corporation with $725.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $725 |
| Janssen Biotech, Inc. JNJ | 26 | $608 |
| AstraZeneca Pharmaceuticals LP AZN | 25 | $541 |
| Pfizer Inc. PFE | 11 | $291 |
| BeOne Medicines USA, Inc. ONC | 8 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $199 |
| Incyte Corporation INCY | 6 | $194 |
| Sobi, Inc SOBI.ST | 5 | $191 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $157 |
| Array Biopharma Inc PFE | 6 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.